241 related articles for article (PubMed ID: 15201932)
1. [Clinical importance of azoles in antifungal therapy: treatment or prophylaxis with new azoles in hematology].
Vazquez Lopez L
Rev Esp Quimioter; 2004 Mar; 17(1):98-100. PubMed ID: 15201932
[No Abstract] [Full Text] [Related]
2. [Azoles: Prophylactic or therapeutic?].
Jarque I
Rev Esp Quimioter; 2004 Mar; 17(1):94-7. PubMed ID: 15201931
[No Abstract] [Full Text] [Related]
3. Updated guidelines for managing fungal diseases in hematology patients.
Hicheri Y; Toma A; Maury S; Pautas C; Mallek-Kaci H; Cordonnier C
Expert Rev Anti Infect Ther; 2010 Sep; 8(9):1049-60. PubMed ID: 20818948
[TBL] [Abstract][Full Text] [Related]
4. [Azole derivatives--new drugs in the treatment of mycoses].
Gwieździński Z; Urbanowski S
Pol Tyg Lek; 1990 Sep 3-10; 45(36-37):740-4. PubMed ID: 2084630
[No Abstract] [Full Text] [Related]
5. Recent approaches to antifungal therapy for invasive mycoses.
Mathew BP; Nath M
ChemMedChem; 2009 Mar; 4(3):310-23. PubMed ID: 19170067
[TBL] [Abstract][Full Text] [Related]
6. [Clinical-microbiological correlation in patients treated with azoles].
Quereda Rodriguez Navarro C
Rev Esp Quimioter; 2004 Mar; 17(1):91-3. PubMed ID: 15201930
[No Abstract] [Full Text] [Related]
7. New azoles as first line therapy for Paecilomyces lilacinus in transplant patients.
Garzoni C; Garbino J
Transpl Infect Dis; 2008 Apr; 10(2):149-50. PubMed ID: 18353095
[No Abstract] [Full Text] [Related]
8. [Antimycotic therapy in clinical practice].
Schaffner A
Schweiz Med Wochenschr; 1991 Sep; 121(39):1413-8. PubMed ID: 1925472
[TBL] [Abstract][Full Text] [Related]
9. Selecting antifungal agents for the treatment of invasive fungal infections in patients with renal failure.
Moudgal VV; Sobel JD
Curr Opin Investig Drugs; 2004 Aug; 5(8):873-8. PubMed ID: 15600244
[TBL] [Abstract][Full Text] [Related]
10. Treatment of invasive fungal infections in high-risk haematological patients: what have we learnt in the past 10 years?
Vallejo C; Vázquez L; Cabrera Martín JR; Carreras E; García Rodríguez J; Ruiz Camps I; Fortún J; Mensa J; Barberán J
Rev Esp Quimioter; 2013 Dec; 26(4):378-86. PubMed ID: 24399355
[TBL] [Abstract][Full Text] [Related]
11. Mycoses--prophylaxis and treatment.
Warmińska J; Kur A; Bartosińska J; Jermak A; Kowal A; Wypyska G; Krasowska D
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):163-7. PubMed ID: 15323186
[TBL] [Abstract][Full Text] [Related]
12. The evolution of azole compounds in antifungal chemotherapy.
Borgers M
J Chemother; 1989 Jul; 1(4 Suppl):238-40. PubMed ID: 16312384
[No Abstract] [Full Text] [Related]
13. Management of fungal infections following allogeneic stem cell transplantation.
Narimatsu H; Kami M
Expert Rev Anti Infect Ther; 2008 Jun; 6(3):373-84. PubMed ID: 18588501
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of fungal infections in hematology and oncology. Guidelines of the Working Party on Infections in Hematology and Oncology (AGIHO) of the German Society for Hematology and Oncology (DGHO)].
Böhme A; Ruhnke M; Karthaus M; Einsele H; Guth S; Heussel G; Heussel CP; Junghanss C; Kern WV; Kubin T; Sezer O; Silling G; Südhoff T; Szelényi H; Ullmann AJ;
Dtsch Med Wochenschr; 2001 Dec; 126(50):1440-7. PubMed ID: 11743682
[No Abstract] [Full Text] [Related]
15. [Prophylaxis of infection in neutropenic patients. Guidelines of the Working Party on Infections in Hematology and Oncology].
Kern WV; Beyer J; Böhme A; Buchheidt D; Cornely O; Einsele H; Kisro J; Krüger W; Maschmeyer G; Ruhnke M; Schmidt CA; Schwartz S; Szelenyi H;
Dtsch Med Wochenschr; 2000 Dec; 125(51-52):1582-8. PubMed ID: 11199452
[No Abstract] [Full Text] [Related]
16. Systemic antifungal therapy in pediatric practice.
Marwaha RK; Maheshwari A
Indian Pediatr; 1999 Oct; 36(10):1011-21. PubMed ID: 10745311
[No Abstract] [Full Text] [Related]
17. Antifungal drugs.
Treat Guidel Med Lett; 2005 Feb; 3(30):7-14. PubMed ID: 15671963
[No Abstract] [Full Text] [Related]
18. New antifungal agents in pediatric practice.
Das S; Shivaprakash MR; Chakrabarti A
Indian Pediatr; 2009 Mar; 46(3):225-31. PubMed ID: 19346570
[TBL] [Abstract][Full Text] [Related]
19. Empiric vs. preemptive antifungal treatment: an appraisal of treatment strategies in haematological patients.
Rieger CT; Ostermann H
Mycoses; 2008; 51 Suppl 1():31-4. PubMed ID: 18471159
[TBL] [Abstract][Full Text] [Related]
20. Recommendations for the treatment of invasive fungal infection caused by filamentous fungi in the hematological patient.
Barberán J; Mensa J; Llamas JC; Ramos IJ; Ruiz JC; Marín JR; Tello PB; Massana MB; Vidal JB; Viñas JM; Huelva FJ; Pons EC; Mediavilla JD; Morfa ML; Barrigón FE; Avellán PF; López SG; García CG; Maraver DH; Guía AL; Jiménez JL; Chacón EM; Rubio MO; Oteyza JP; Ramírez GR; Contreras RR; Barbero AR; Tarrats MR; Félix DR; Godoy PS; Salinas AS; Alonso MA; Torroba Jde L; Ferreiras DV; López LV; García JM; Perea JR; Moreno RC; Cáncer RC; Abete JF; Rodríguez JG; Gómez JG; Pedrosa EG; Baranda JM; García FJ; Camps IR; Lleti MS; Cisneros Jde L;
Rev Esp Quimioter; 2011 Dec; 24(4):263-70. PubMed ID: 22173196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
